Van Well Daan 4
4 · SOPHiA GENETICS SA · Filed Apr 14, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CLO Daan Van Well Sells 2,400 Shares
What Happened
Daan Van Well, Chief Legal Officer of SOPHiA GENETICS (SOPH), sold 2,400 shares in an open-market transaction on April 10, 2026 for a weighted average price of $4.67, generating proceeds of approximately $11,201. The filing indicates these sales were executed to satisfy tax withholding obligations related to restricted stock unit vesting, and were made under a pre-established Rule 10b5-1 trading plan (non-discretionary).
Key Details
- Transaction date: April 10, 2026; Form 4 filed April 14, 2026 (filed 4 days after the trade; later than the typical 2-business-day window).
- Shares sold: 2,400; Weighted average price reported: $4.67; price range across multiple trades: $4.61–$4.77.
- Proceeds: ~$11,201.
- Reason/footnotes: Sales were to satisfy tax withholding on RSU vestings (April 2–3, 2026) and were executed pursuant to a pre-established Rule 10b5-1(c) plan (non-discretionary). The filer can provide per-price sale details on request.
- Shares owned after the transaction: Not specified in the Form 4 filing.
Context
These were routine tax-withholding sales tied to RSU vesting rather than discretionary liquidations; sales under 10b5-1 plans are typically pre-scheduled and do not necessarily signal the insider’s view of the stock. For retail investors, purchases generally carry more informational weight than routine sales for tax purposes.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-04-10$4.67/sh−2,400$11,201→ 346,420 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.